High cardiovascular risk in HIV patients research hub

A randomised, double-blind, multicenter, placebo-controlled clinical trial of colchicine to reduce coronary artery inflammation in people with HIV. COLCOHIV

This study looks at whether a drug called colchicine can reduce inflammation in the heart's arteries for people with HIV who are at high risk of heart problems. Researchers will compare it to a dummy pill to see if it helps keep hearts healthier.